Establishment Historical Balance Sheet

ESTA Stock

USD 33.76 0.07 0.21%

Trend analysis of Establishment Labs Holdings balance sheet accounts such as Short and Long Term Debt Total of 232.1 M or Other Current Liab of 14.5 M provides information on Establishment Labs' total assets, liabilities, and equity, which is the actual value of Establishment Labs to its prevalent stockholders. By breaking down trends over time using Establishment Labs balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Establishment Labs latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Establishment Labs is a good buy for the upcoming year.

Establishment Labs Inventory

96.53 Million

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Establishment Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Establishment Labs at a specified time, usually calculated after every quarter, six months, or one year. Establishment Labs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Establishment Labs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Establishment currently owns. An asset can also be divided into two categories, current and non-current.

Establishment Labs Balance Sheet Chart

At present, Establishment Labs' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 232.1 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 21.8 M.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Establishment Labs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Establishment Labs books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from Establishment Labs' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Establishment Labs current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	178.7M	192.2M	221.1M	232.1M
Total Assets	211.1M	268.6M	308.9M	324.4M

Short Long Term Debt Total Total Assets

Establishment Labs balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity
Common Stock Shares Outstanding		0.82	0.64	0.65	-0.45	0.68	0.25	0.48	0.64	0.36	0.38	-0.84	0.64	0.81	0.64	0.36	-0.44	0.81	0.79	0.91	0.91	0.75	0.86	0.74	0.83	0.83
Total Assets	0.82		0.93	0.49	-0.35	0.55	-0.02	0.22	0.93	0.41	0.73	-0.97	0.92	0.73	0.94	0.75	-0.19	0.73	0.99	0.82	0.86	0.98	0.96	0.97	0.84	0.98
Short Long Term Debt Total	0.64	0.93		0.41	-0.06	0.2	-0.33	-0.15	0.99	0.52	0.92	-0.91	0.95	0.48	0.98	0.87	0.14	0.48	0.94	0.58	0.67	0.98	0.88	0.93	0.77	0.93
Other Current Liab	0.65	0.49	0.41		-0.06	0.27	0.01	0.15	0.41	0.61	0.28	-0.56	0.42	0.46	0.41	0.16	-0.4	0.46	0.51	0.67	0.53	0.47	0.7	0.43	0.56	0.62
Total Current Liabilities	-0.45	-0.35	-0.06	-0.06		-0.85	-0.7	-0.87	-0.05	0.47	0.27	0.27	-0.04	-0.75	-0.05	0.2	0.75	-0.75	-0.28	-0.59	-0.56	-0.22	-0.3	-0.23	-0.32	-0.25
Total Stockholder Equity	0.68	0.55	0.2	0.27	-0.85		0.68	0.93	0.23	-0.18	-0.16	-0.5	0.27	0.86	0.24	0.01	-0.77	0.86	0.47	0.79	0.76	0.36	0.51	0.45	0.5	0.47
Other Liab	0.25	-0.02	-0.33	0.01	-0.7	0.68		0.8	-0.29	-0.24	-0.56	0.08	-0.27	0.39	-0.29	-0.48	-0.85	0.39	-0.06	0.47	0.24	-0.17	0.0	-0.08	0.02	-0.06
Net Tangible Assets	0.48	0.22	-0.15	0.15	-0.87	0.93	0.8		-0.13	-0.38	-0.5	-0.2	-0.11	0.75	-0.12	-0.36	-0.81	0.75	0.13	0.6	0.57	0.03	0.21	0.09	0.3	0.15
Property Plant And Equipment Net	0.64	0.93	0.99	0.41	-0.05	0.23	-0.29	-0.13		0.55	0.92	-0.9	0.99	0.45	1.0	0.91	0.1	0.45	0.96	0.6	0.66	0.97	0.88	0.96	0.72	0.94
Current Deferred Revenue	0.36	0.41	0.52	0.61	0.47	-0.18	-0.24	-0.38	0.55		0.58	-0.43	0.53	0.04	0.54	0.49	0.14	0.04	0.45	0.35	0.2	0.47	0.52	0.45	0.41	0.52
Net Debt	0.38	0.73	0.92	0.28	0.27	-0.16	-0.56	-0.5	0.92	0.58		-0.72	0.9	0.11	0.92	0.93	0.4	0.11	0.79	0.29	0.36	0.84	0.68	0.81	0.52	0.76
Retained Earnings	-0.84	-0.97	-0.91	-0.56	0.27	-0.5	0.08	-0.2	-0.9	-0.43	-0.72		-0.89	-0.72	-0.9	-0.69	0.14	-0.72	-0.96	-0.8	-0.89	-0.96	-0.96	-0.92	-0.9	-0.97
Accounts Payable	0.64	0.92	0.95	0.42	-0.04	0.27	-0.27	-0.11	0.99	0.53	0.9	-0.89		0.42	0.99	0.93	0.05	0.42	0.95	0.61	0.64	0.94	0.87	0.98	0.67	0.93
Cash	0.81	0.73	0.48	0.46	-0.75	0.86	0.39	0.75	0.45	0.04	0.11	-0.72	0.42		0.45	0.13	-0.54	1.0	0.65	0.84	0.92	0.62	0.72	0.56	0.81	0.67
Non Current Assets Total	0.64	0.94	0.98	0.41	-0.05	0.24	-0.29	-0.12	1.0	0.54	0.92	-0.9	0.99	0.45		0.92	0.09	0.45	0.96	0.6	0.65	0.97	0.88	0.97	0.72	0.94
Non Currrent Assets Other	0.36	0.75	0.87	0.16	0.2	0.01	-0.48	-0.36	0.91	0.49	0.93	-0.69	0.93	0.13	0.92		0.34	0.13	0.79	0.29	0.36	0.8	0.64	0.85	0.43	0.74
Other Assets	-0.44	-0.19	0.14	-0.4	0.75	-0.77	-0.85	-0.81	0.1	0.14	0.4	0.14	0.05	-0.54	0.09	0.34		-0.54	-0.16	-0.65	-0.39	-0.03	-0.28	-0.12	-0.16	-0.2
Cash And Short Term Investments	0.81	0.73	0.48	0.46	-0.75	0.86	0.39	0.75	0.45	0.04	0.11	-0.72	0.42	1.0	0.45	0.13	-0.54		0.65	0.84	0.92	0.62	0.72	0.56	0.81	0.67
Net Receivables	0.79	0.99	0.94	0.51	-0.28	0.47	-0.06	0.13	0.96	0.45	0.79	-0.96	0.95	0.65	0.96	0.79	-0.16	0.65		0.79	0.82	0.98	0.96	0.99	0.81	0.99
Good Will	0.91	0.82	0.58	0.67	-0.59	0.79	0.47	0.6	0.6	0.35	0.29	-0.8	0.61	0.84	0.6	0.29	-0.65	0.84	0.79		0.9	0.71	0.87	0.74	0.79	0.82
Common Stock Total Equity	0.91	0.86	0.67	0.53	-0.56	0.76	0.24	0.57	0.66	0.2	0.36	-0.89	0.64	0.92	0.65	0.36	-0.39	0.92	0.82	0.9		0.79	0.86	0.75	0.91	0.83
Non Current Liabilities Total	0.75	0.98	0.98	0.47	-0.22	0.36	-0.17	0.03	0.97	0.47	0.84	-0.96	0.94	0.62	0.97	0.8	-0.03	0.62	0.98	0.71	0.79		0.94	0.95	0.84	0.97
Capital Surpluse	0.86	0.96	0.88	0.7	-0.3	0.51	0.0	0.21	0.88	0.52	0.68	-0.96	0.87	0.72	0.88	0.64	-0.28	0.72	0.96	0.87	0.86	0.94		0.91	0.88	0.99
Inventory	0.74	0.97	0.93	0.43	-0.23	0.45	-0.08	0.09	0.96	0.45	0.81	-0.92	0.98	0.56	0.97	0.85	-0.12	0.56	0.99	0.74	0.75	0.95	0.91		0.72	0.96
Other Current Assets	0.83	0.84	0.77	0.56	-0.32	0.5	0.02	0.3	0.72	0.41	0.52	-0.9	0.67	0.81	0.72	0.43	-0.16	0.81	0.81	0.79	0.91	0.84	0.88	0.72		0.85
Other Stockholder Equity	0.83	0.98	0.93	0.62	-0.25	0.47	-0.06	0.15	0.94	0.52	0.76	-0.97	0.93	0.67	0.94	0.74	-0.2	0.67	0.99	0.82	0.83	0.97	0.99	0.96	0.85

Click cells to compare fundamentals

Establishment Labs Account Relationship Matchups

Establishment Labs balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	23.3M	24.0M	24.5M	25.6M	29.4M	21.8M
Total Assets	156.4M	139.5M	211.1M	268.6M	308.9M	324.4M
Short Long Term Debt Total	51.8M	53.8M	178.7M	192.2M	221.1M	232.1M
Other Current Liab	14.2M	16.2M	16.5M	12.8M	14.7M	14.5M
Total Current Liabilities	25.9M	31.9M	39.0M	57.2M	51.4M	30.6M
Total Stockholder Equity	75.0M	50.7M	(8.2M)	18.4M	21.2M	29.4M
Other Liab	5.5M	3.8M	3.1M	1.6M	1.5M	1.4M
Net Tangible Assets	35.7M	70.3M	45.9M	(13.3M)	(15.2M)	(14.5M)
Property Plant And Equipment Net	18.8M	20.9M	54.8M	80.6M	92.7M	97.3M
Current Deferred Revenue	1.2M	769K	1.7M	1.8M	2.1M	1.5M
Net Debt	(32.8M)	391K	112.3M	152.2M	175.0M	183.8M
Retained Earnings	(165.2M)	(206.4M)	(281.6M)	(360.1M)	(324.1M)	(307.9M)
Accounts Payable	9.7M	14.5M	20.0M	41.6M	47.9M	50.3M
Cash	84.5M	53.4M	66.4M	40.0M	46.0M	47.6M
Non Current Assets Total	24.1M	26.3M	61.2M	93.7M	107.8M	113.2M
Non Currrent Assets Other	664K	558K	1.3M	4.7M	5.4M	5.7M
Other Assets	368K	664K	558K	1.3M	1.5M	785.7K
Cash And Short Term Investments	84.5M	53.4M	66.4M	40.0M	46.0M	47.6M
Net Receivables	19.1M	24.4M	35.4M	46.9M	54.0M	56.7M
Common Stock Total Equity	147.7M	213.5M	219.7M	223.6M	257.2M	156.9M
Liabilities And Stockholders Equity	156.4M	139.5M	211.1M	268.6M	308.9M	324.4M
Non Current Liabilities Total	55.5M	56.9M	180.3M	193.1M	222.1M	233.2M
Capital Surpluse	21.2M	26.7M	36.6M	49.9M	57.4M	60.3M
Inventory	23.2M	28.4M	36.6M	79.9M	91.9M	96.5M
Other Current Assets	5.4M	7.0M	11.5M	8.0M	9.2M	5.6M
Other Stockholder Equity	23.9M	33.7M	47.1M	60.9M	70.0M	73.5M
Total Liab	81.4M	88.8M	219.2M	250.2M	287.8M	302.2M
Property Plant And Equipment Gross	18.8M	20.9M	54.8M	96.9M	111.4M	117.0M
Total Current Assets	132.3M	113.3M	149.9M	174.9M	201.1M	112.4M
Accumulated Other Comprehensive Income	2.9M	3.7M	2.7M	2.0M	2.3M	1.5M
Non Current Liabilities Other	2.3M	2.4M	175.5M	147K	169.1K	160.6K
Short Term Debt	948K	402K	688K	773K	695.7K	660.9K
Intangible Assets	4.1M	4.4M	4.6M	8.0M	9.2M	4.6M
Common Stock	213.5M	219.7M	223.6M	315.6M	363.0M	381.1M
Property Plant Equipment	16.4M	16.2M	20.9M	51.1M	58.8M	61.7M
Long Term Debt	49.8M	51.9M	175.5M	188.7M	217.0M	227.9M
Net Invested Capital	124.8M	102.6M	175.5M	207.1M	238.2M	127.1M
Net Working Capital	106.4M	81.4M	110.9M	117.8M	135.4M	87.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock:

How To Invest In Establishment

Details

Is Establishment Stock a good investment?

Details

What is Establishment Labs' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.59)

Revenue Per Share

5.58

Quarterly Revenue Growth

0.045

Return On Assets

(0.12)

Return On Equity

(2.23)

The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Establishment Historical Balance Sheet

Establishment Labs Inventory

96.53 Million

About Establishment Balance Sheet Analysis

Establishment Labs Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Establishment Labs balance sheet Correlations

Establishment Labs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Establishment Labs balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Net Receivables	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Short Long Term Debt Total
Accounts Payable	+ 0.99	Property Plant And Equipment Net
Non Current Assets Total	+ 0.99	Accounts Payable

Other Stockholder Equity	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Total Assets
Capital Surpluse	- 0.96	Retained Earnings
Non Current Liabilities Total	- 0.96	Retained Earnings
Net Receivables	- 0.96	Retained Earnings
Inventory	- 0.92	Retained Earnings